These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

772 related articles for article (PubMed ID: 30257375)

  • 1. A review on recent drug delivery systems for posterior segment of eye.
    Nayak K; Misra M
    Biomed Pharmacother; 2018 Nov; 107():1564-1582. PubMed ID: 30257375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug delivery to the posterior segment of the eye.
    Thrimawithana TR; Young S; Bunt CR; Green C; Alany RG
    Drug Discov Today; 2011 Mar; 16(5-6):270-7. PubMed ID: 21167306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modern drug delivery systems for targeting the posterior segment of the eye.
    Peptu CA; Popa M; Savin C; Popa RF; Ochiuz L
    Curr Pharm Des; 2015; 21(42):6055-69. PubMed ID: 26503152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Nanotherapies for the Posterior Segment of the Eye: An Integrative Review on Recent Advancements and Challenges.
    Gogoi NR; Marbaniang D; Pal P; Ray S; Mazumder B
    Pharm Nanotechnol; 2022 Nov; 10(4):268-278. PubMed ID: 35946098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis.
    Myles ME; Neumann DM; Hill JM
    Adv Drug Deliv Rev; 2005 Dec; 57(14):2063-79. PubMed ID: 16310884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periocular routes for retinal drug delivery.
    Raghava S; Hammond M; Kompella UB
    Expert Opin Drug Deliv; 2004 Nov; 1(1):99-114. PubMed ID: 16296723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New techniques for drug delivery to the posterior eye segment.
    Eljarrat-Binstock E; Pe'er J; Domb AJ
    Pharm Res; 2010 Apr; 27(4):530-43. PubMed ID: 20155388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances.
    Wang R; Gao Y; Liu A; Zhai G
    J Drug Target; 2021 Aug; 29(7):687-702. PubMed ID: 33474998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in ophthalmic preparations: Ocular barriers, dosage forms and routes of administration.
    Maulvi FA; Shetty KH; Desai DT; Shah DO; Willcox MDP
    Int J Pharm; 2021 Oct; 608():121105. PubMed ID: 34537269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of microneedles in delivering drugs for various ocular diseases.
    Gupta P; Yadav KS
    Life Sci; 2019 Nov; 237():116907. PubMed ID: 31606378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug delivery to the posterior segment of the eye.
    Fischer N; Narayanan R; Loewenstein A; Kuppermann BD
    Eur J Ophthalmol; 2011; 21 Suppl 6():S20-6. PubMed ID: 23264325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of therapeutics for deep-seated ocular conditions - status quo.
    Nguyen H; Eng S; Ngo T; Dass CR
    J Pharm Pharmacol; 2018 Aug; 70(8):994-1001. PubMed ID: 29675844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can (Natural) deep eutectic systems increase the efficacy of ocular therapeutics?
    Sarmento C; Duarte ARC; Rita Jesus A
    Eur J Pharm Biopharm; 2024 May; 198():114276. PubMed ID: 38582179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges and strategies for ocular posterior diseases therapy via non-invasive advanced drug delivery.
    Qi Q; Wei Y; Zhang X; Guan J; Mao S
    J Control Release; 2023 Sep; 361():191-211. PubMed ID: 37532148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in ocular drug delivery: emphasis on the posterior segment.
    Kang-Mieler JJ; Osswald CR; Mieler WF
    Expert Opin Drug Deliv; 2014 Oct; 11(10):1647-60. PubMed ID: 24975820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical devices for the treatment of eye diseases.
    Yasukawa T; Ogura Y
    Handb Exp Pharmacol; 2010; (197):469-89. PubMed ID: 20217540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posterior drug delivery via periocular route: challenges and opportunities.
    Waite D; Wang Y; Jones D; Stitt A; Raj Singh TR
    Ther Deliv; 2017 Jul; 8(8):685-699. PubMed ID: 28730942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye.
    Fangueiro JF; Veiga F; Silva AM; Souto EB
    Curr Pharm Des; 2016; 22(9):1135-46. PubMed ID: 26675225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in ocular drug delivery.
    Chen H
    J Drug Target; 2015; 23(7-8):597-604. PubMed ID: 26453157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of lipid nanoparticles to ocular drug delivery.
    Battaglia L; Serpe L; Foglietta F; Muntoni E; Gallarate M; Del Pozo Rodriguez A; Solinis MA
    Expert Opin Drug Deliv; 2016 Dec; 13(12):1743-1757. PubMed ID: 27291069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.